Kiran Mazumdar-Shaw expects DCGI nod for Oxford Covid vaccine in emergency cases

Published On 2020-11-25 08:05 GMT | Update On 2020-11-25 12:43 GMT

New Delhi: Biocon Executive Chairperson Kiran Mazumdar-Shaw on Tuesday said hopefully drugs regulator DCGI will give Emergency Use Authorization (EUA) for the Oxford-AstraZeneca's COVID-19 vaccine as soon as it gets approval from the UK's Medicines and Healthcare products Regulatory Agency.

"100 Million Doses By January," Says Adar Poonawalla On Oxford Vaccine - hopefully DCGI will give EUA immediately after MHRA in December to start vaccination in India which is the need of the hour," Mazumdar-Shaw said in a tweet.

On Monday, Poonawalla had said that by January, Serum Institute will have 100 million doses. It already has 40 million doses.

He had also expressed happiness at pharma major AstraZeneca's announcement that its Covid-19 vaccine candidate has been found to be 70 percent effective on average.

Serum is conducting clinical trials of Oxford University-AstraZeneca's Covid-19 vaccine candidate in India.

On Monday, AstraZeneca had said one dosing regimen showed vaccine efficacy of 90 percent when the vaccine was given as a half-dose followed by a full dose at least one month apart, while another dosing regimen showed 62 percent efficacy when given as two full doses at least one month apart.

"The combined analysis from both dosing regimens resulted in an average efficacy of 70 percent," it had said.

AstraZeneca also said it is making rapid progress in manufacturing with a capacity of up to 3 billion doses of the vaccine in 2021 on a rolling basis, pending regulatory approval.

"The vaccine can be stored, transported and handled at normal refrigerated conditions for at least six months and administered within existing healthcare settings," it added.

India saw 37,975 new coronavirus infections in a day taking the country's Covid-19 caseload to 91.77 lakh, while recoveries crossed 86 lakh, according to the Union Health Ministry data updated on Tuesday.

Read also: Biocon Biologics approves Rs 1,125 crore investment from Goldman Sachs

Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Kiran Mazumdar-Shaw expects DCGI nod for Oxford Covid vaccine in emergency cases

Similar News

Zydus Foundation Vice Chairperson Meha Patel appointed as Member of CII National Committee on Art & Culture for 2025-26

Eris Lifesciences Secures CDSCO Panel Nod to Conduct BE Study on Dapagliflozin, Pioglitazone, Metformin FDC

Delhi to form special committee to crush fake medicine racket

Roche Pharma teams up with 10 Govt Hospitals to power up clinical trial capacities in India

AstraZeneca's Proposal to Increase Sample Size in Zibotentan-Dapagliflozin Global Trial Gets SEC Nod

Govt Allows Stickering, Orders New MRPs Post GST Reduction, AiMeD Welcomes Directive

Sun Pharma Secures Interim Court Relief In URSOCOL Trademark Dispute

Nellore Horror: 21-year-old B.Pharm student stabbed to death